¶ HECTD1 Protein (HECT Domain E3 Ubiquitin Protein Ligase 1)
| HECTD1 Protein |
|---|
| Protein Name | HECT domain E3 ubiquitin protein ligase 1 |
| Gene | [HECTD1](/genes/hectd1) |
| UniProt ID | [Q9P2M7](https://www.uniprot.org/uniprot/Q9P2M7) |
| Alternative Names | HECT domain-containing protein 1, E3 ubiquitin ligase HECTD1 |
| Molecular Weight | ~280 kDa |
| Subcellular Localization | Cytoplasm, nucleus, endoplasmic reticulum |
| Protein Family | HECT (Homologous to E6AP C-Terminus) E3 ligase family |
| Enzyme Activity | E3 ubiquitin-protein ligase |
HECTD1 is a member of the HECT (Homologous to E6AP C-Terminus) family of E3 ubiquitin ligases. These enzymes catalyze the transfer of ubiquitin to substrate proteins, targeting them for degradation, modification, or altered cellular localization. HECTD1 has been implicated in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis (ALS) through its roles in protein quality control, autophagy, and cellular stress responses.
¶ Structure and Function
¶ HECT Domain Architecture
HECTD1 contains multiple functional domains:
- N-terminal domain: Contains the substrate recognition region
- Linker region: Connects substrate-binding and catalytic domains
- HECT domain: ~350 amino acid catalytic domain with ubiquitin-binding cysteine
- C-terminal region: Regulatory elements
HECTD1 catalyzes ubiquitination through:
- E2 enzyme recruitment: HECT domain binds ubiquitin-conjugating enzymes (E2)
- Thioester formation: Ubiquitin forms a thioester bond with the HECT cysteine
- Substrate transfer: Ubiquitin is transferred to lysine residues on substrates
- Chain formation: HECTD1 can build polyubiquitin chains
HECTD1 contributes to AD through protein quality control:
- Amyloid-beta clearance: May ubiquitinate Aβ aggregates for degradation
- Tau pathology: Involved in tau turnover and clearance
- ER stress: Modulates unfolded protein response
- Autophagy regulation: Controls selective autophagy pathways
In PD, HECTD1 functions in:
- Alpha-synuclein turnover: Mediates degradation of alpha-synuclein
- Mitophagy: Participates in mitochondrial quality control
- Parkin interaction: May cooperate with parkin in ubiquitination
- LRRK2 pathways: Interactions with LRRK2 kinase signaling
In ALS, HECTD1 is involved in:
- TDP-43 metabolism: Regulates TDP-43 ubiquitination and clearance
- Protein aggregate clearance: Autophagy of aggregation-prone proteins
- Stress granule dynamics: Modulates stress granule assembly
- Motor neuron survival: Loss of function contributes to degeneration
HECTD1 contributes to neurodegeneration through:
- Proteostasis disruption: Failure to clear damaged proteins
- Autophagy impairment: Defective selective autophagy
- ER stress: Unfolded protein response dysregulation
- Mitochondrial dysfunction: Impaired mitophagy
HECTD1 is a potential therapeutic target:
- Activators: Compounds that enhance HECTD1 activity could boost protein clearance
- Inhibitors: Blocking pathological ubiquitination
- Substrate-specific modulators: Targeting specific HECTD1 substrates
Key challenges in targeting HECTD1:
- Specificity: Achieving selective modulation
- Blood-brain barrier: CNS drug delivery
- Complexity: Understanding substrate diversity
HECTD1 variants are associated with:
- Neurodegenerative disease risk: Some GWAS signals
- Developmental disorders: Mutations cause autism spectrum disorders
- Cancer: Altered expression in various cancers
HECTD1 may serve as:
- Disease marker: Expression levels in patient samples
- Therapeutic target: Modulating protein clearance
- Ubiquitin-Proteasome System in Neurodegeneration
- Protein Quality Control in Neurodegeneration
- Autophagy in Neurodegeneration ER Stress in Neurodegeneration